Muscle Relaxant Drugs Market Size

Muscle Relaxant Drugs Market Size

Muscle Relaxant Drugs Market size was valued to be USD 4.1 billion in 2022 and is expected to reach USD 9.4 billion in 2032 with a CAGR of 6.4% from 2023 to 2032. The market's significant growth is primarily driven by the rising geriatric population coupled with growing prevalence of chronic pain along with lower back pain.

To get key market trends

  Download Free Sample

For instance, in 2022, according to World Health Organization (WHO), the lower back pain affected nearly 619 million people globally and it is estimated that the number of cases will increase to 843 million cases by 2050. Therefore, patient awareness towards pain management drugs for the musculoskeletal r disorders along with the surge in drug discovery & development is expected to propel the growth of the market.

Muscle relaxant drugs, also known as muscle relaxants, are a class of drugs that are used to reduce muscle tension, stiffness, and spasms. They work by affecting the central nervous system or the muscle itself to alleviate discomfort and improve mobility in conditions associated with muscle-related issues. They are prescribed for various conditions such as neck, & low back pain, myofascial pain syndrome and fibromyalgia among other conditions. In addition, they are also used during surgical interventions along with general aesthetics for muscle relaxation.